共 50 条
[41]
Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China
[J].
Cell Biochemistry and Biophysics,
2013, 67
:957-963
[42]
Live networks in care production with the user at the center of the treatment for multidrug-resistant tuberculosis
[J].
INTERFACE-COMUNICACAO SAUDE EDUCACAO,
2024, 28
[43]
Live networks in care production with the user at the center of the treatment for multidrug-resistant tuberculosis
[J].
INTERFACE-COMUNICACAO SAUDE EDUCACAO,
2024, 28
[45]
Barriers to tuberculosis control and prevention in undergraduates in Xi’an, China: A qualitative study
[J].
Journal of Public Health Policy,
2010, 31
:355-368
[47]
Treatment outcome of multidrug-resistant tuberculosis in Japan – the first cross-sectional study of Japan tuberculosis surveillance data
[J].
BMC Infectious Diseases,
18